Accelerating consumer health revenue growth:
Consumer health revenue growth of 30% in FY2019, up from 25% in FY2018.
Improved operating results:
Consumer health operating results improved with a 42% reduction in operating loss to $0.7 million, down from $1.2 million in FY2018.
Investing for global growth:
Significant investment in senior management team, distribution channels, e-commerce and digital market capabilities plus operational efficiencies.
Guidance confirmed:
Cellmid is on track to reach operating profitability in the consumer health business in FY2020.
